Aristea Translational Medicine Corp

Aims are commercialization of a patent pending drug for Concussion and prevention of secondary Chronic Traumatic Encephalopathy and Alzheimer's disease .

  • Stage Product In Development
  • Industry Biotechnology
  • Location Park City, UT, US
  • Currency USD
  • Founded May 2012
  • Employees 1
  • Website aristeatranslationalmedicine.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free